|
TTF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.985700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.845200E-01 |
| Normal-vs-Stage2 |
1.027570E-01 |
| Normal-vs-Stage3 |
5.735800E-01 |
| Normal-vs-Stage4 |
2.691400E-01 |
| Stage1-vs-Stage2 |
4.373800E-01 |
| Stage1-vs-Stage3 |
8.198200E-01 |
| Stage1-vs-Stage4 |
7.206000E-01 |
| Stage2-vs-Stage3 |
3.613200E-01 |
| Stage2-vs-Stage4 |
8.098400E-01 |
| Stage3-vs-Stage4 |
6.065000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.043900E-02 |
| Normal-vs-AfricanAmerican |
1.394600E-01 |
| Normal-vs-Asian |
4.324600E-01 |
| Caucasian-vs-AfricanAmerican |
9.188600E-01 |
| Caucasian-vs-Asian |
2.759200E-01 |
| AfricanAmerican-vs-Asian |
1.640570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.109800E-01 |
| Normal-vs-Female |
1.279850E-02 |
| Male-vs-Female |
3.216200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.923000E-01 |
| Normal-vs-Extreme_Weight |
4.380200E-01 |
| Normal-vs-Obese |
4.282000E-02 |
| Normal-vs-Extreme_Obese |
5.378600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.520400E-01 |
| Normal_Weight-vs-Obese |
2.506200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.946200E-01 |
| Extreme_Weight-vs-Obese |
1.429790E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.037000E-01 |
| Obese-vs-Extreme_Obese |
1.598170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.181210E-01 |
| Normal-vs-Age(41-60Yrs) |
1.621800E-02 |
| Normal-vs-Age(61-80Yrs) |
5.813800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.691000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.612400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.580000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.203800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.537500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.644200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.803400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.084200E-03 |
| Normal-VS-Type2 PRCC |
1.118820E-01 |
| Normal-VS-KIRP CIMP |
1.108550E-01 |
| Normal-VS-Unclassified PRCC |
2.373400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.88940000206617E-08 |
| Type1 PRCC-VS-KIRP CIMP |
4.923200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.647200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.357800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.811550E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.627200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.540000E-01 |
| Normal-vs-N1 |
7.838200E-02 |
| Normal-vs-N2 |
3.762600E-01 |
| N0-vs-N1 |
5.075700E-02 |
| N0-vs-N2 |
3.724400E-01 |
| N1-vs-N2 |
7.762000E-01 |
|
|
